Licensing Deals May Become More Adversarial Following MedImmune Ruling

The Supreme Court's ruling that MedImmune is entitled to challenge a patent it is licensing from Genentech will likely create a more contentious environment for parties negotiating licensing deals

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet